MARSHAL BLATT: Open Payments
NPI 1699882423 · MONTEREY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,562 in 451 payments from 15 companies in 2025. Trend: 2023 $4,460 · 2024 $4,500 · 2025 $6,562
Food & beverage: $6,362Education: $200
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 89 | $1,022 |
| Axsome Therapeutics, Inc. | 69 | $1,011 |
| Neurocrine BioSciences, Inc. | 58 | $983 |
| ABBVIE INC. | 56 | $672 |
| Otsuka America Pharmaceutical, Inc. | 40 | $496 |
| Teva Pharmaceuticals USA, Inc. | 23 | $472 |
| Vanda Pharmaceuticals Inc. | 35 | $468 |
| Lundbeck LLC | 19 | $395 |
| E.R. Squibb & Sons, L.L.C. | 15 | $366 |
| Alkermes, Inc. | 24 | $310 |
Products named: CAPLYTA, INGREZZA, Auvelity, REXULTI, VRAYLAR, FANAPT, COBENFY, ARISTADA.
Industry payments across CA — which companies pay providers there.
